Stay updated on Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-28T16:17:48.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition-related updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-21T21:53:21.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision indicator changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-14T21:57:25.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T22:11:28.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The study page is now a 403 error, removing the previous study details and replacing them with a 403 Forbidden message and a Home link.
    Difference
    19%
    Check dated 2026-09-23T21:43:54.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The page now shows revision: v3.7.0 in place of the previous v3.6.6. This reflects a software update to the site's underlying revision.
    Difference
    0.1%
    Check dated 2026-09-16T22:01:53.000Z thumbnail image

Stay in the know with updates to Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page.